{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:16:29Z","timestamp":1785402989113,"version":"3.56.0"},"reference-count":20,"publisher":"Akademiai Kiado Zrt.","issue":"13","license":[{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2025,3,30]]},"abstract":"<jats:p>\n                    <jats:italic>Bevezet\u00e9s:<\/jats:italic>\n                    A prosztatar\u00e1k diagnosztik\u00e1ja folyamatosan fejl\u0151dik,\n                    de a pontos ter\u00e1pi\u00e1s tervez\u00e9shez ma is elengedhetetlen a t\u00f6bbnyire biopszi\u00e1val\n                    nyert minta sz\u00f6vettani azonos\u00edt\u00e1sa. A kor\u00e1bban tapint\u00e1svez\u00e9rl\u00e9ssel ir\u00e1ny\u00edtott\n                    mintav\u00e9telez\u00e9st ma m\u00e1r lev\u00e1ltotta a k\u00e9palkot\u00e1s seg\u00edts\u00e9g\u00e9vel t\u00f6rt\u00e9n\u0151 biopszia.\n                    Ennek jelenlegi legmodernebb v\u00e1ltozata a multiparametrikus MR-k\u00e9palkot\u00e1s \u00e9s az\n                    ultrahangc\u00e9lz\u00e1s f\u00fazi\u00f3j\u00e1ra t\u00e1maszkodik. Az elj\u00e1r\u00e1s egyik sarkalatos pontja az\n                    MR-k\u00e9pek megfelel\u0151 j\u00e1rtass\u00e1g\u00fa szakember \u00e1ltali elemz\u00e9se. Ezt a folyamatot\n                    t\u00e1mogatja, illetve az inform\u00e1ci\u00f3\u00e1tvitelben rejl\u0151 hibafaktorokat seg\u00edt\n                    kik\u00fcsz\u00f6b\u00f6lni a mesters\u00e9gesintelligencia-alap\u00fa digit\u00e1lis tervez\u00e9s.\n                    <jats:italic>C\u00e9lkit\u0171z\u00e9s:<\/jats:italic>\n                    C\u00e9lul t\u0171zt\u00fck ki, hogy ismertess\u00fck a\n                    mesters\u00e9gesintelligencia-alap\u00fa k\u00e9pelemz\u00e9sre \u00e9p\u00fcl\u0151 \u00e9s h\u00e1romdimenzi\u00f3s virtu\u00e1lis\n                    modellez\u00e9sen alapul\u00f3, transperinealis prosztata-mintav\u00e9telez\u00e9s sor\u00e1n szerzett\n                    tapasztalatainkat.\n                    <jats:italic>M\u00f3dszer:<\/jats:italic>\n                    Int\u00e9zet\u00fcnkben 2020. november \u00e9s\n                    2024. \u00e1prilis k\u00f6z\u00f6tt Watson Elementary\n                    <jats:sup>\u00ae<\/jats:sup>\n                    mesters\u00e9gesintelligencia-alap\u00fa \u00e9s PI-RADS- (v. 2.1) besorol\u00e1s szerinti\n                    k\u00e9pelemz\u00e9st, valamint h\u00e1romdimenzi\u00f3s digit\u00e1lis modellez\u00e9st k\u00f6vet\u0151en, altat\u00e1sban,\n                    a BiopSee\n                    <jats:sup>\u00ae<\/jats:sup>\n                    g\u00e1ton kereszt\u00fcli mintav\u00e9telez\u0151 \u00e1llom\u00e1s alkalmaz\u00e1s\u00e1val 227\n                    prosztatabiopszi\u00e1t v\u00e9gezt\u00fcnk. Eredm\u00e9nyeinket retrospekt\u00edven elemezt\u00fck.\n                    <jats:italic>Eredm\u00e9nyek:<\/jats:italic>\n                    A fenti id\u0151szakban 227 prosztatar\u00e1kgyan\u00fas beteg\n                    biopszi\u00e1ja t\u00f6rt\u00e9nt meg. Az \u00e1tlag\u00e9letkor 66,7 \u00b1 7,8 \u00e9v, az \u00e1tlagos PSA-\u00e9rt\u00e9k 14,3\n                    ng\/ml volt. A m\u0171t\u0151ben t\u00f6lt\u00f6tt \u00e1tlagos id\u0151 26,2 perc volt. Fert\u0151z\u00e9ses sz\u00f6v\u0151dm\u00e9ny\n                    nem alakult ki. Spont\u00e1n sz\u0171n\u0151 haematuri\u00e1t vagy haematospermi\u00e1t 86 esetben\n                    regisztr\u00e1ltunk. Transurethralis kat\u00e9tert 7 esetben helyezt\u00fcnk fel, 5-\u00f6t azonban\n                    24 \u00f3r\u00e1n bel\u00fcl elt\u00e1vol\u00edtottunk. A tumortal\u00e1lati ar\u00e1ny PI-RADS 3-as besorol\u00e1s\n                    eset\u00e9n 18%, PI-RADS 4-es kapcs\u00e1n 72%, PI-RADS 5-\u00f6s mellett 95,5% volt. A\n                    klinikailag szignifik\u00e1ns prosztatar\u00e1k megoszl\u00e1sa ezeknek megfelel\u0151en 7%, 44%,\n                    illetve 84% volt. Az igazol\u00f3dott prosztatar\u00e1k kapcs\u00e1n 48 radik\u00e1lis\n                    prostatectomia t\u00f6rt\u00e9nt. Akt\u00edv k\u00f6vet\u00e9sen 20 beteget vezet\u00fcnk.\n                    <jats:italic>Megbesz\u00e9l\u00e9s:<\/jats:italic>\n                    A prosztatabiopszi\u00e1k kapcs\u00e1n k\u00e9t felmer\u00fcl\u0151\n                    probl\u00e9ma \u2013 a klinikailag jelent\u0151s r\u00e1kok tal\u00e1lati ar\u00e1nya \u00e9s a fert\u0151z\u00e9si kock\u00e1zat\n                    \u2013 a szakter\u00fcletet folyamatos fejl\u0151d\u00e9sre \u00f6szt\u00f6nzi. A\n                    mesters\u00e9gesintelligencia-alap\u00fa MR-elemz\u00e9s a legjobban k\u00e9pzett radiol\u00f3gus\n                    szakemberek \u00e1ltal v\u00e9gzett elemz\u00e9sekhez hasonl\u00f3 hat\u00e1sfokkal k\u00e9pes meghat\u00e1rozni a\n                    tumorgyan\u00fas ter\u00fcleteket. A digit\u00e1lismodell-alap\u00fa, g\u00e1ton kereszt\u00fcli f\u00fazi\u00f3s\n                    biopszi\u00e1s technika nagy precizit\u00e1ssal, kifejezetten kis fert\u0151z\u00e9si kock\u00e1zat\n                    mellett k\u00e9pes el\u00e9rni diagnosztikus c\u00e9lj\u00e1t.\n                    <jats:italic>K\u00f6vetkeztet\u00e9s:<\/jats:italic>\n                    A\n                    mesters\u00e9gesintelligencia-alap\u00fa elemz\u00e9s \u00e9s a digit\u00e1lismodell-alap\u00fa,\n                    transperinealis f\u00fazi\u00f3s biopszia nagy betegbiztons\u00e1got \u00e9s transzparens\n                    diagnosztikai seg\u00edts\u00e9get ny\u00fajt. Az int\u00e9zet\u00fcnk protokollja ment\u00e9n v\u00e9gzett\n                    transperinealis mintav\u00e9tel a fert\u0151z\u00e9s kock\u00e1zat\u00e1t gyakorlatilag null\u00e1ra\n                    minimaliz\u00e1lta. A k\u00e9palkot\u00e1s standardiz\u00e1l\u00e1sa \u00e9s a mintav\u00e9telez\u00e9si protokollok\n                    technikai egys\u00e9ges\u00edt\u00e9se seg\u00edtheti a diagnosztikus \u00e9s az arra \u00e9p\u00fcl\u0151 ter\u00e1pi\u00e1s\n                    d\u00f6nt\u00e9shozatalt. Orv Hetil. 2025; 166(13): 503\u2013510.\n                  <\/jats:p>","DOI":"10.1556\/650.2025.33214","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T02:32:47Z","timestamp":1743388367000},"page":"503-510","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":2,"title":["Mesters\u00e9gesintelligencia-alap\u00fa f\u00fazi\u00f3s prosztatabiopszia"],"prefix":"10.1556","volume":"166","author":[{"given":"S\u00e1ndor","family":"P\u00f3th","sequence":"first","affiliation":[{"name":"Szegedi Tudom\u00e1nyegyetem, Orvostudom\u00e1nyi Kar, Szent-Gy\u00f6rgyi Albert Klinikai K\u00f6zpont, Urol\u00f3giai Klinika Szeged Magyarorsz\u00e1g"},{"name":"Budai Eg\u00e9szs\u00e9gk\u00f6zpont, Nemzetk\u00f6zi MRT- \u00e9s Mesters\u00e9ges Intelligencia Vez\u00e9relt Diagnosztikai K\u00f6zpont Budapest, Kir\u00e1lyh\u00e1g\u00f3 u. 3., 1126 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"T\u00far\u00f3czi-Kirizs","sequence":"additional","affiliation":[{"name":"Budai Eg\u00e9szs\u00e9gk\u00f6zpont, Radiol\u00f3gia Div\u00edzi\u00f3 Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Kov\u00e1cs","sequence":"additional","affiliation":[{"name":"Budai Eg\u00e9szs\u00e9gk\u00f6zpont, Nemzetk\u00f6zi MRT- \u00e9s Mesters\u00e9ges Intelligencia Vez\u00e9relt Diagnosztikai K\u00f6zpont Budapest, Kir\u00e1lyh\u00e1g\u00f3 u. 3., 1126 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Bajory","sequence":"additional","affiliation":[{"name":"Szegedi Tudom\u00e1nyegyetem, Orvostudom\u00e1nyi Kar, Szent-Gy\u00f6rgyi Albert Klinikai K\u00f6zpont, Urol\u00f3giai Klinika Szeged Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Gravestock P, Somani BK, Tokas T, et al. A review of modern imaging\n                    landscape for prostate cancer: a comprehensive clinical guide. J Clin Med. 2023;\n                    12: 1186.","DOI":"10.3390\/jcm12031186"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Bjurlin MA, Taneja SS. Standards for prostate biopsy. Curr Opin\n                    Urol. 2014; 24: 155\u2013161.","DOI":"10.1097\/MOU.0000000000000031"},{"key":"R3","unstructured":"American College of Radiology. Prostate Imaging Reporting & Data\n                    System (PI-RADS\u00ae). Available from:\n                        https:\/\/www.acr.org\/Clinical-Resources\/Clinical-Tools-and-Reference\/Reporting-and-Data-Systems\/PI-RADS\n                    [accessed: 22 January, 2025]."},{"key":"R4","doi-asserted-by":"crossref","unstructured":"H\u00fcttl A. Diagnosis of prostate cancer \u2013 fusion biopsy. [A\n                    prosztatar\u00e1k diagnosztik\u00e1ja \u2013 f\u00fazi\u00f3s biopszia.] Magy Urol. 2023; 35: 66\u201368.\n                    [Hungarian]","DOI":"10.22591\/magyurol.2023.2.huttla.66"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Gaziev G, Wadhwa K, Barrett T, et al. Defining the learning curve\n                    for multiparametric magnetic resonance imaging (MRI) of the prostate using\n                    MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate\n                    biopsies as a validation tool. BJU Int. 2016; 117: 80\u201386.","DOI":"10.1111\/bju.12892"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Shin T, Smyth TB, Ukimura O, et al. Diagnostic accuracy of a\n                    five-point Likert scoring system for magnetic resonance imaging (MRI) evaluated\n                    according to results of MRI\/ultrasonography image-fusion targeted biopsy of the\n                    prostate. BJU Int. 2018; 121: 77\u201383.","DOI":"10.1111\/bju.13972"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Matoso A, Epstein J. Defining clinically significant prostate cancer\n                    on the basis of pathological finding. Histopathology 2019; 74:\n                    135\u2013145.","DOI":"10.1111\/his.13712"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"R\u00e1fi T, Volford G, Z\u00f3ber T, et al. MRI-ultrasound fusion-guided\n                    prostate biopsy at P\u00e9terfy Hospital. [MR-f\u00fazi\u00f3s ultrahangvez\u00e9relt\n                    prosztatabiopszia a P\u00e9terfy K\u00f3rh\u00e1zban.] Magy Urol. 2021; 33: 97\u2013103.\n                    [Hungarian]","DOI":"10.22591\/magyurol.2021.3.rafit.97"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"G\u00e1ti Zs, Tenke P. How long and by whom it should be postponed to\n                    perform a prostate biopsy during COVID-19 pandemic? \u2013 A comparison of prostate\n                    cancer diagnostic procedures between 2019 and 2020 in the Jahn Ferenc South-Pest\n                    Hospital. [Meddig \u00e9s kin\u00e9l szabad halasztani a prosztatabiopszi\u00e1t a\n                    COVID\u201319-pand\u00e9mia alatt? A Jahn Ferenc D\u00e9l-pesti K\u00f3rh\u00e1zban v\u00e9gzett\n                    prosztatar\u00e1k-diagnosztikai beavatkoz\u00e1sok \u00f6sszehasonl\u00edt\u00e1sa 2019-ben \u00e9s 2020-ban.]\n                    Magy Urol. 2022; 34: 76\u201378. [Hungarian]","DOI":"10.22591\/magyurol.2022.2.gatizs.76"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Jonson DC, Raman SS, Mirak SA, et al. Detection of individual\n                    prostate cancer foci via multiparametric magnetic resonance imaging. Eur Urol.\n                    2019; 75: 712\u2013720.","DOI":"10.1016\/j.eururo.2018.11.031"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Kalina I. Diagnosis of the prostate cancer. [A prosztatar\u00e1k\n                    diagnosztik\u00e1ja.] Magy Urol. 2023; 35: 57\u201360. [Hungarian]","DOI":"10.22591\/magyurol.2023.2.kalinai.57"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"H\u00fcttl AB, Korda \u00c1D, L\u00e9n\u00e1rd MZs, et al. Our initial experiences with\n                    mpMRI-ultrasound fusion-guided prostate biopsy. [Kezdeti tapasztalataink az mpMR\n                    f\u00fazi\u00f3s ultrahangvez\u00e9relt prosztatabiopszi\u00e1val.] Orv Hetil. 2020; 161: 2188\u20132194.\n                    [Hungarian]","DOI":"10.1556\/650.2020.31942"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"McKinney SM, Sienjek M, Godbole V, et al. International evaluation\n                    of an AI system for breast cancer screening. Nature 2020; 577:\n                    89\u201394.","DOI":"10.1038\/s41586-019-1799-6"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Buzog\u00e1ny I, Dombov\u00e1ri P, R\u00e1fi T, et al. Active monitoring of\n                    prostate cancer with multiparametric magnetic resonance imaging: present and\n                    future perspectives. [A prosztatar\u00e1k akt\u00edv megfigyel\u00e9se multiparametrikus\n                    m\u00e1gnesesrezonancia k\u00e9palkot\u00e1ssal: a jelen \u00e9s a j\u00f6v\u0151 perspekt\u00edv\u00e1ja.] Magy Urol.\n                    2021; 33: 154\u2013162. [Hungarian]","DOI":"10.22591\/magyurol.2021.4.buzoganyi.154"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Roethke M, Kuru T, Mueller-Wolf MB, et al. Evaluation of an\n                    automated analysis tool for prostate cancer prediction using multiparametric\n                    magnetic resonance imaging. PLoS ONE 2016; 11: e0159803.","DOI":"10.1371\/journal.pone.0159803"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Nam KR, Saskin R, Lee Y, et al. Increasing hospital admission rates\n                    for urological complications after transrectal ultrasound guided prostate\n                    biopsy. J Urol. 2013; 189(Suppl): S12\u2013S18.","DOI":"10.1016\/j.juro.2012.11.015"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Kar\u00e1szi \u00c9, Onoz\u00f3 B, Kulcs\u00e1r A, et al. Reducing the risk of\n                    infections in hereditary and acquired complement deficiencies. [Infekci\u00f3k\n                    kock\u00e1zat\u00e1nak cs\u00f6kkent\u00e9se velesz\u00fcletett \u00e9s szerzett komplementdefektusokban.] Orv\n                    Hetil. 2023; 164: 971\u2013980. [Hungarian]","DOI":"10.1556\/650.2023.32798"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Holub L, Szab\u00f3 BG, Z\u00e1vorszky L, et al. Pharmacokinetic and\n                    pharmacodynamic considerations of antibiotic therapy among critically ill adult\n                    patients with sepsis. [Kritikus \u00e1llapot\u00fa, szeptikus feln\u0151tt betegek\n                    antibiotikumkezel\u00e9snek farmakokinetikai \u00e9s farmakodinamikai megfontol\u00e1sai.] Orv\n                    Hetil. 2024; 165: 403\u2013415. [Hungarian]","DOI":"10.1556\/650.2024.33001"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Maihoub S, Krasznai M, Moln\u00e1r A, et al. A comparison of locally\n                    acting antiseptics, increasingly recommended as an alternative to antibiotics.\n                    [Az antibiotikumok alternat\u00edv\u00e1jak\u00e9nt egyre gyakrabban aj\u00e1nlott, helyileg\n                    alkalmazhat\u00f3 antiszeptikumok \u00f6sszehasonl\u00edt\u00e1sa.] Orv Hetil. 2024; 165: 1621\u20131627.\n                    [Hungarian]","DOI":"10.1556\/650.2024.33125"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Sz\u00e9kely E, Borka K. Pathology of prostate cancer. [A prosztatar\u00e1k\n                    patol\u00f3gi\u00e1ja.] Magy Urol. 2023; 35: 69\u201374. [Hungarian]","DOI":"10.22591\/magyurol.2023.2.szekelye.69"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/166\/13\/article-p503.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/166\/13\/article-p503.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.akjournals.com\/downloadpdf\/journals\/650\/166\/13\/article-p503.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:54:41Z","timestamp":1785401681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.akjournals.com\/view\/journals\/650\/166\/13\/article-p503.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,30]]},"references-count":20,"journal-issue":{"issue":"13"},"URL":"https:\/\/doi.org\/10.1556\/650.2025.33214","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,30]]}}}